about fansalaran
FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer (BAYGn.DE), opens new tab announced...
US FDA approves Insmed’s drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's...
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
The FDA granted fast track designation to NRX-100 (NRx...
Swiss government to meet pharma firms to discuss US tariffs
The Swiss government is due to meet this week...
Pfizer’s combination therapy improves survival in bladder cancer trial
Pfizer (PFE.N), opens new tab said on Tuesday its...
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer (BAYGn.DE), opens new tab announced...
US FDA approves Insmed’s drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's...
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
The FDA granted fast track designation to NRX-100 (NRx...
Swiss government to meet pharma firms to discuss US tariffs
The Swiss government is due to meet this week...
Pfizer’s combination therapy improves survival in bladder cancer trial
Pfizer (PFE.N), opens new tab said on Tuesday its...
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer (BAYGn.DE), opens new tab announced...
US FDA approves Insmed’s drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's...
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
The FDA granted fast track designation to NRX-100 (NRx...
Swiss government to meet pharma firms to discuss US tariffs
The Swiss government is due to meet this week...
Pfizer’s combination therapy improves survival in bladder cancer trial
Pfizer (PFE.N), opens new tab said on Tuesday its...
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer (BAYGn.DE), opens new tab announced...
US FDA approves Insmed’s drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's...
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
The FDA granted fast track designation to NRX-100 (NRx...
Swiss government to meet pharma firms to discuss US tariffs
The Swiss government is due to meet this week...
Pfizer’s combination therapy improves survival in bladder cancer trial
Pfizer (PFE.N), opens new tab said on Tuesday its...
"Fansalaran showcases the latest news and the top pharmaceutical brands in the country. With Fansalaran, you can be seen globally."
Headlines
Bayer adds cancer drug candidate to portfolio with $1.3-billion Kumquat deal
German pharmaceutical group Bayer (BAYGn.DE), opens new tab announced...
US FDA approves Insmed’s drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's...
Ketamine-Based Drug Receives FDA Fast Track Designation for Suicidal Ideation
The FDA granted fast track designation to NRX-100 (NRx...
Swiss government to meet pharma firms to discuss US tariffs
The Swiss government is due to meet this week...
Fansalaran
Get important news delivered directly to your inbox and stay connected!